MetaCap

CONMED Corporation (CNMD)

NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

46.56+0.18 (+0.39%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CNMD stock chart

Technical analysis

Key statistics

All statistics
Ex-dividend date
Sep 15, 2025
52-week range
31.44 – 54.80
Day range
45.94 – 48.00
Volume / Avg
384.26K / 364.31K
Beta
—

52-week range

$31.44$54.80

CNMD stock today

Shares of CONMED (CNMD) finished higher on Nov 20 at $46.56, a gain of 0.39% or $0.18 per share, versus the S&P 500's 3.70% decline. At this level, CNMD sits in the middle of its 52-week range of $31.44 to $54.80: 15.0% below the high, set on Nov 5, 2026 and 48.1% above the low. CNMD is up 14.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 8.8%.

At 19.3x trailing earnings, CONMED trades above the peer-group median of 10.4x. Its forward P/E of 9.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About CONMED

Company profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Patrick J. Beyer
Headquarters
Largo, FL
Employees
3,900
IPO year
1987
Website
conmed.com

Financial highlights

Full financials

In fiscal 2025, CONMED generated $1.37 billion in revenue, up 5.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $47.1 million (-64.5% year over year), for a net margin of 3.4% versus a median of 5.2% in the prior 5 years. Gross margin was 54.6% (down from 56.1%) and operating margin 7.5%.

CONMED annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.37B$1.31B$1.24B$1.05B$1.01B
Growth+5.18%+5.00%+19.06%+3.45%+17.18%
Net income$47.05M$132.42M$64.46M$-80.58M$62.54M
EPS (diluted)$1.51$4.25$2.04$-2.68$1.94

Analyst forecast

Forecast

Consensus (7 analysts)

hold

Avg. price target

$46.83+0.58%

  • Strong buy 0
  • Buy 0
  • Hold 6
  • Sell 0
  • Strong sell 1

Target range

Low $43.00High $50.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 28, 2026
EPS actual vs est.
$0.66 vs $1.00
Surprise
-34.00%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.20
Ex-dividend date
Sep 15, 2025

CNMD news

All CNMD news

CONMED peers

Health Care sector
CNMD peer companies
CompanyPrice% ChgMarket capCompare
CBLLCeriBell Inc.27.39+6.37%$1.06Bvs CNMD
INMDInMode Ltd.12.42-2.20%$714.70Mvs CNMD
CVCapsoVision Inc.6.11-3.17%$327.56Mvs CNMD
ELMDElectromed Inc.22.98-1.20%$187.84Mvs CNMD
FOCLEDAP TMS S.A. ADR2.61-7.45%$123.25Mvs CNMD
VANIVivani Medical Inc.1.14+4.59%$102.83Mvs CNMD
STXSStereotaxis Inc.0.9422-6.71%$95.03Mvs CNMD
HSDTSolana Company Class A1.49-10.24%$93.70Mvs CNMD

Indexes, lists and sector

CONMED stock FAQ

What is CONMED's stock price today?

CNMD last traded at $46.56 as of Nov 20, 4:00 PM EST, up 0.39% on the day. Prices are delayed at least 15 minutes.

Does CONMED pay a dividend?

Yes. CONMED pays $0.00 per share annually. The most recent dividend of $0.20 had an ex-dividend date of Sep 15, 2025.

What is CNMD's P/E ratio?

CNMD trades at a trailing P/E ratio of 19.32 and a forward P/E of 9.80, compared with a median of 10.4 for its closest peers.

Who is CONMED's CEO?

Mr. Patrick J. Beyer is the chief executive officer of CONMED Corporation, which has about 3,900 employees.

Has CNMD ever split its stock?

Yes. The most recent CNMD stock split was a 3-for-2 split on Sep 10, 2001, one of 3 splits on record.

What is the CNMD 52-week high?

The 52-week high for CNMD is $54.80 and the 52-week low is $31.44. The stock is currently 15.0% below its high.

Compare CNMD